Eleusis Benefit Corporation seeks to develop and repurpose restricted small molecule drugs to safely address critical unmet needs. Founded by Shlomi Raz in 2013, Eleusis Benefit is headquartered in New York.
The Pulse of New York Tech
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.